SUN PHARMACEUTICAL INDUSTRIESS
Sun Pharma deal structurally strong, debt the only overhang: Amit KhuranaMarket expert Amit Khurana offers insights on key corporate and regulatory developments. Sun Pharma's acquisition is seen as strategically ...
A two-wheeler major which is defying industry trend and a pharma stock with option for sideways tradeThe price of this stock has been rising steadily after taking support from the lower trendline of a falling channel. Now the price has give...
Market now: 19 stocks hit 52-week high amid better monsoon forecastOverall, 34 shares were trading in green in Nifty50 index, while 16 were trading in red in the afternoon trade.
Market now: Pharma stocks surge up to 9% ahead of RBI's monetary policy outcomeRBI held repo rate at a six-year low of 6.25 per cent on April 6, 2017 and reverse repo rate by 0.25 per cent to 6 per cent.
Load More